The discovery of receptor tyrosine kinases: targets for cancer therapy (original) (raw)

• Levi-Montalcini, R. Effects of mouse tumor transplantation on the nervous system. Ann. NY Acad. Sci. 55, 330–344 (1952).
  Article CAS PubMed Google Scholar
• Cohen, S. & Levi-Montalcini, R. Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180. Cancer Res. 17, 15–20 (1957).
  CAS PubMed Google Scholar
• Levi-Montalcini, R. & Cohen, S. Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals. Ann. NY Acad. Sci. 85, 324–341 (1960).
  CAS PubMed Google Scholar
• Cohen, S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem. 237, 1555–1562 (1962).
  Article CAS PubMed Google Scholar
• Cohen, S. The stimulation of epidermal proliferation by a specific protein (EGF). Dev. Biol. 12, 394–407 (1965).
  Article CAS PubMed Google Scholar
• Carpenter, G., Lembach, K. J., Morrison, M. M. & Cohen, S. Characterization of the binding of 125I-labeled epidermal growth factor to human fibroblasts. J. Biol. Chem. 250, 4297–4304 (1975).
  Article CAS PubMed Google Scholar
• Carpenter, G., King, L. Jr & Cohen, S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 276, 409–410 (1978).
  Article CAS PubMed Google Scholar
• Eckhart, W., Hutchinson, M. A. & Hunter, T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell 18, 925–933 (1979).
  Article CAS PubMed Google Scholar
• Hunter, T. & Sefton, B. M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl Acad. Sci. USA 77, 1311–1315 (1980).
  Article CAS PubMed PubMed Central Google Scholar
• Ushiro, H. & Cohen, S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J. Biol. Chem. 255, 8363–8365 (1980).
  Article CAS PubMed Google Scholar
• Kasuga, M., Zick, Y., Blithe, D. L., Crettaz, M. & Kahn, C. R. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298, 667–669 (1982).
  Article CAS PubMed Google Scholar
• Ek, B., Westermark, B., Wasteson, A. & Heldin, C. H. Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature 295, 419–420 (1982).
  Article CAS PubMed Google Scholar
• Hunter, T. & Cooper, J. A. Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell 24, 741–752 (1981).
  Article CAS PubMed Google Scholar
• Cooper, J. A., Bowen-Pope, D. F., Raines, E., Ross, R. & Hunter, T. Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell 31, 263–273 (1982).
  Article CAS PubMed Google Scholar
• Ullrich, A. et al. Rat insulin genes: construction of plasmids containing the coding sequences. Science 196, 1313–1319 (1977).
  Article CAS PubMed Google Scholar
• Sures, I., Goeddel, D. V., Gray, A. & Ullrich, A. Nucleotide sequence of human preproinsulin complementary DNA. Science 208, 57–59 (1980).
  Article CAS PubMed Google Scholar
• Gray, A., Dull, T. J. & Ullrich, A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 303, 722–725 (1983).
  Article CAS PubMed Google Scholar
• Scott, J. et al. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science 221, 236–240 (1983).
  Article CAS PubMed Google Scholar
• Dull, T. J., Gray, A., Hayflick, J. S. & Ullrich, A. Insulin-like growth factor II precursor gene organization in relation to insulin gene family. Nature 310, 777–781 (1984).
  Article CAS PubMed Google Scholar
• Ullrich, A., Gray, A., Berman, C. & Dull, T. J. Human β-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303, 821–825 (1983).
  Article CAS PubMed Google Scholar
• Johnsson, A. et al. The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J. 3, 921–928 (1984).
  Article CAS PubMed PubMed Central Google Scholar
• Chiu, I. M. et al. Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor. Cell 37, 123–129 (1984).
  Article CAS PubMed Google Scholar
• Derynck, R., Roberts, A. B., Winkler, M. E., Chen, E. Y. & Goeddel, D. V. Human transforming growth factor-α: precursor structure and expression in E. coli. Cell 38, 287–297 (1984).
  Article CAS PubMed Google Scholar
• Itakura, K. et al. Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198, 1056–1063 (1977).
  Article CAS PubMed Google Scholar
• Martial, J. A., Hallewell, R. A., Baxter, J. D. & Goodman, H. M. Human growth hormone: complementary DNA cloning and expression in bacteria. Science 205, 602–607 (1979).
  Article CAS PubMed Google Scholar
• Ullrich, A. et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418–425 (1984).
  Article CAS PubMed Google Scholar
• Downward, J. et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307, 521–527 (1984).
  Article CAS PubMed Google Scholar
• Yamamoto, T., Hihara, H., Nishida, T., Kawai, S. & Toyoshima, K. A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell 34, 225–232 (1983).
  Article CAS PubMed Google Scholar
• Ullrich, A. et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313, 756–761 (1985).
  Article CAS PubMed Google Scholar
• Ebina, Y. et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40, 747–758 (1985).
  Article CAS PubMed Google Scholar
• Ullrich, A. et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5, 2503–2512 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Yarden, Y. et al. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323, 226–232 (1986).
  Article CAS PubMed Google Scholar
• Yarden, Y. et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6, 3341–3351 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Coussens, L. et al. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature 320, 277–280 (1986).
  Article CAS PubMed Google Scholar
• Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355–365 (2001).
  Article CAS PubMed Google Scholar
• Riedel, H., Dull, T. J., Schlessinger, J. & Ullrich, A. A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor. Nature 324, 68–70 (1986).
  Article CAS PubMed Google Scholar
• Schlessinger, J. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13, 443–447 (1988).
  Article CAS PubMed Google Scholar
• Wiesmann, C. et al. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695–704 (1997).
  Article CAS PubMed Google Scholar
• Wiesmann, C., Ultsch, M. H., Bass, S. H. & de Vos, A. M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–188 (1999).
  Article CAS PubMed Google Scholar
• Lemmon, M. A. et al. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 16, 281–294 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ogiso, H. et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775–787 (2002).
  Article CAS PubMed Google Scholar
• Garrett, T. P. et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 110, 763–773 (2002).
  Article CAS PubMed Google Scholar
• Kamata, T. & Feramisco, J. R. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins. Nature 310, 147–150 (1984).
  Article CAS PubMed Google Scholar
• Smith, M. R., DeGudicibus, S. J. & Stacey, D. W. Requirement for c-ras proteins during viral oncogene transformation. Nature 320, 540–543 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Margolis, B. et al. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57, 1101–1107 (1989).
  Article CAS PubMed Google Scholar
• Meisenhelder, J., Suh, P. G., Rhee, S. G. & Hunter, T. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57, 1109–1122 (1989).
  Article CAS PubMed Google Scholar
• Moran, M. F. et al. Src homology region 2 domains direct protein–protein interactions in signal transduction. Proc. Natl Acad. Sci. USA 87, 8622–8626 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuda, M., Mayer, B. J., Fukui, Y. & Hanafusa, H. Binding of transforming protein, p47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248, 1537–1539 (1990).
  Article CAS PubMed Google Scholar
• Wolfman, A. & Macara, I. G. A cytosolic protein catalyzes the release of GDP from p21ras. Science 248, 67–69 (1990).
  Article CAS PubMed Google Scholar
• Downward, J., Riehl, R., Wu, L. & Weinberg, R. A. Identification of a nucleotide exchange-promoting activity for p21ras. Proc. Natl Acad. Sci. USA 87, 5998–6002 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Lowenstein, E. J. et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70, 431–442 (1992).
  Article CAS PubMed Google Scholar
• Matuoka, K., Shibata, M., Yamakawa, A. & Takenawa, T. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries. Proc. Natl Acad. Sci. USA 89, 9015–9019 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Matuoka, K., Shibasaki, F., Shibata, M. & Takenawa, T. Ash/Grb-2, a SH2/SH3-containing protein, couples to signaling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J. 12, 3467–3473 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• McCormick, F. Signal transduction. How receptors turn Ras on. Nature 363, 15–16 (1993).
  Article CAS PubMed Google Scholar
• Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179–185 (1995).
  Article CAS PubMed Google Scholar
• Bjorge, J. D., Chan, T. O., Antczak, M., Kung, H. J. & Fujita, D. J. Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. Proc. Natl Acad. Sci. USA 87, 3816–3820 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Franke, T. F. et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727–736 (1995).
  Article CAS PubMed Google Scholar
• Zhong, Z., Wen, Z. & Darnell, J. E. Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95–98 (1994).
  Article CAS PubMed Google Scholar
• Yamauchi, T. et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390, 91–96 (1997).
  Article CAS PubMed Google Scholar
• Moro, L. et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17, 6622–6632 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zwick, E. et al. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J. Biol. Chem. 272, 24767–24770 (1997).
  Article CAS PubMed Google Scholar
• King, C. R., Borrello, I., Porter, L., Comoglio, P. & Schlessinger, J. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock. Oncogene 4, 13–18 (1989).
  CAS PubMed Google Scholar
• Daub, H., Weiss, F. U., Wallasch, C. & Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557–560 (1996).
  Article CAS PubMed Google Scholar
• Prenzel, N. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884–888 (1999).
  Article CAS PubMed Google Scholar
• Gschwind, A., Hart, S., Fischer, O. M. & Ullrich, A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 22, 2411–2421 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Asakura, M. et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nature Med. 8, 35–40 (2002).
  Article CAS PubMed Google Scholar
• Lemjabbar, H. & Basbaum, C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nature Med. 8, 41–46 (2002).
  Article CAS PubMed Google Scholar
• Keates, S. et al. cag+Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells. J. Biol. Chem. 276, 48127–48134 (2001).
  Article CAS PubMed Google Scholar
• Threadgill, D. W. et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269, 230–234 (1995).
  Article CAS PubMed Google Scholar
• Miettinen, P. J. et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376, 337–341 (1995).
  Article CAS PubMed Google Scholar
• Sibilia, M. & Wagner, E. F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234–238 (1995).
  Article CAS PubMed Google Scholar
• Lee, K. F. et al. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378, 394–398 (1995).
  Article CAS PubMed Google Scholar
• Erickson, S. L. et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124, 4999–5011 (1997).
  Article CAS PubMed Google Scholar
• Gassmann, M. et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378, 390–394 (1995).
  Article CAS PubMed Google Scholar
• Luetteke, N. C. et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739–2750 (1999).
  Article CAS PubMed Google Scholar
• Luetteke, N. C. et al. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73, 263–278 (1993).
  Article CAS PubMed Google Scholar
• Mann, G. B. et al. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73, 249–261 (1993).
  Article CAS PubMed Google Scholar
• Iwamoto, R. et al. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl Acad. Sci. USA 100, 3221–3226 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Jackson, L. F. et al. Defective valvulogenesis in HB-EGF and _TACE_-null mice is associated with aberrant BMP signaling. EMBO J. 22, 2704–2716 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Black, R. A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385, 729–733 (1997).
  Article CAS PubMed Google Scholar
• Peschon, J. J. et al. An essential role for ectodomain shedding in mammalian development. Science 282, 1281–1284 (1998).
  Article CAS PubMed Google Scholar
• Sunnarborg, S. W. et al. Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277, 12838–12845 (2002).
  Article CAS PubMed Google Scholar
• Sizeland, A. M. & Burgess, A. W. Anti-sense transforming growth factor α oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. Mol. Biol. Cell 3, 1235–1243 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Humphrey, P. A. et al. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc. Natl Acad. Sci. USA 87, 4207–4211 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Malden, L. T., Novak, U., Kaye, A. H. & Burgess, A. W. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res. 48, 2711–2714 (1988).
  CAS PubMed Google Scholar
• Peschard, P. & Park, M. Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell 3, 519–523 (2003).
  Article CAS PubMed Google Scholar
• Levkowitz, G. et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12, 3663–3674 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Thien, C. B. & Langdon, W. Y. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene 15, 2909–2919 (1997).
  Article CAS PubMed Google Scholar
• Coussens, L. et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132–1139 (1985).
  Article CAS PubMed Google Scholar
• King, C. R., Kraus, M. H. & Aaronson, S. A. Amplification of a novel v-_erbB_-related gene in a human mammary carcinoma. Science 229, 974–976 (1985).
  Article CAS PubMed Google Scholar
• Schechter, A. L. et al. The neu oncogene: an _erb-B_-related gene encoding a 185,000-Mr tumour antigen. Nature 312, 513–516 (1984).
  Article CAS PubMed Google Scholar
• Drebin, J. A., Stern, D. F., Link, V. C., Weinberg, R. A. & Greene, M. I. Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature 312, 545–548 (1984).
  Article CAS PubMed Google Scholar
• Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177–182 (1987).
  Article CAS PubMed Google Scholar
• Slamon, D. J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712 (1989).
  Article CAS PubMed Google Scholar
• Stern, D. F. & Kamps, M. P. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. EMBO J. 7, 995–1001 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• King, C. R., Borrello, I., Bellot, F., Comoglio, P. & Schlessinger, J. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J. 7, 1647–1651 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Graus-Porta, D., Beerli, R. R., Daly, J. M. & Hynes, N. E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16, 1647–1655 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Hudziak, R. M. et al. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol. 9, 1165–1172 (1989).
  CAS PubMed PubMed Central Google Scholar
• Fendly, B. M. et al. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res. 50, 1550–1558 (1990).
  CAS PubMed Google Scholar
• Agus, D. B. et al. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell 2, 127–137 (2002).
  Article CAS PubMed Google Scholar
• Kawamoto, T. et al. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl Acad. Sci. USA 80, 1337–1341 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Sato, J. D. et al. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol. Biol. Med. 1, 511–529 (1983).
  CAS PubMed Google Scholar
• Yaish, P., Gazit, A., Gilon, C. & Levitzki, A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 242, 933–935 (1988).
  Article CAS PubMed Google Scholar
• Honegger, A. M. et al. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51, 199–209 (1987).
  Article CAS PubMed Google Scholar
• Honegger, A. M. et al. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol. Cell. Biol. 7, 4568–4571 (1987).
  CAS PubMed PubMed Central Google Scholar
• Redemann, N. et al. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. Cell. Biol. 12, 491–498 (1992).
  CAS PubMed PubMed Central Google Scholar
• Fry, D. W. et al. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265, 1093–1095 (1994).
  Article CAS PubMed Google Scholar
• Osherov, N. & Levitzki, A. Epidermal-growth-factor-dependent activation of the src-family kinases. Eur. J. Biochem. 225, 1047–1053 (1994).
  Article CAS PubMed Google Scholar
• Wakeling, A. E. et al. Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines. Breast Cancer Res. Treat. 38, 67–73 (1996).
  Article CAS PubMed Google Scholar
• Druker, B. J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells. Nature Med. 2, 561–566 (1996).
  Article CAS PubMed Google Scholar
• Buchdunger, E. et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J. Pharmacol. Exp. Ther. 295, 139–145 (2000).
  CAS PubMed Google Scholar
• Joensuu, H. et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 344, 1052–1056 (2001).
  Article CAS PubMed Google Scholar
• Ferrara, N. VEGF and the quest for tumour angiogenesis factors. Nature Rev. Cancer 2, 795–803 (2002).
  Article CAS Google Scholar
• Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182–1186 (1971).
  Article CAS PubMed Google Scholar
• de Vries, C. et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989–991 (1992).
  Article CAS PubMed Google Scholar
• Terman, B. I. et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579–1586 (1992).
  Article CAS PubMed Google Scholar
• Millauer, B. et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835–846 (1993).
  Article CAS PubMed Google Scholar
• Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N. & Williams, L. T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA 90, 7533–7537 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Fong, G. H., Rossant, J., Gertsenstein, M. & Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66–70 (1995).
  Article CAS PubMed Google Scholar
• Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66 (1995).
  Article CAS PubMed Google Scholar
• Kim, K. J. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841–844 (1993).
  Article CAS PubMed Google Scholar
• Millauer, B., Shawver, L. K., Plate, K. H., Risau, W. & Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576–579 (1994).
  Article CAS PubMed Google Scholar
• Millauer, B. et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615–1620 (1996).
  CAS PubMed Google Scholar
• Presta, L. G. et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 57, 4593–4599 (1997).
  CAS PubMed Google Scholar
• Fong, T. A. et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59, 99–106 (1999).
  CAS PubMed Google Scholar
• Shaheen, R. M. et al. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res. 59, 5412–5416 (1999).
  CAS PubMed Google Scholar
• O'Farrell, A. M. et al. SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo. Blood 101, 3597–3605 (2003).
  Article CAS PubMed Google Scholar
• Wedge, S. R. et al. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res. 62, 4645–4655 (2002).
  CAS PubMed Google Scholar
• Wood, J. M. et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 60, 2178–2189 (2000).
  CAS PubMed Google Scholar
• Gorre, M. E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR–ABL gene mutation or amplification. Science 293, 876–880 (2001).
  Article CAS PubMed Google Scholar
• Heinrich, M. C. et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J. Clin. Oncol. 21, 4342–4349 (2003).
  Article CAS PubMed Google Scholar
• Bardelli, A. et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).
  Article CAS PubMed Google Scholar
• Soriano, P. The PDGF α receptor is required for neural crest cell development and for normal patterning of the somites. Development 124, 2691–2700 (1997).
  Article CAS PubMed Google Scholar
• Soriano, P. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 8, 1888–1896 (1994).
  Article CAS PubMed Google Scholar
• Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442 (1996).
  Article CAS PubMed Google Scholar
• Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439 (1996).
  Article CAS PubMed Google Scholar